Rite Aid Opens More Than 300 New No-Charge COVID-19 Testing Sites
February 04 2021 - 10:00AM
Business Wire
Drive-Through Testing Expanding Across New
Jersey, New York and Pennsylvania
Rite Aid (NYSE: RAD) is expanding its no-charge COVID-19 testing
capabilities with 317 additional drive-through testing site
locations opening across New Jersey, New York and Pennsylvania on
Friday, February 5, through its partnership with the U.S.
Department of Health and Human Services (HHS).
Like Rite Aid's existing testing sites, the new locations will
utilize PCR, simple self-swab nasal tests overseen by Rite Aid
pharmacists. Each site will operate Monday through Friday 10 a.m. -
8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m., with testing only
available through the chain’s drive-through windows to ensure the
safety of customers seeking other services in-store.
Rite Aid's COVID-19 nasal tests are available for all
individuals four years of age and older, regardless if they are
experiencing virus symptoms, in accordance with the Centers for
Disease Control and Prevention (CDC) guidance.
Customers are required to pre-register online at www.riteaid.com
in order to schedule a time slot for testing. Individuals ages 4-17
may access testing with parent or legal guardian consent.
Additionally, a parent or legal guardian must be in attendance and
bring their photo ID to the testing appointment with the minor.
Now operating 777 total testing sites across 16 states, Rite Aid
has adequate capacity to test symptomatic and asymptomatic
individuals four years and older who want to be tested. A complete
list of Rite Aid's COVID-19 testing sites can also be found at
www.riteaid.com.
Rite Aid partners with Verily and its Baseline COVID-19 Testing
Program to provide screening, scheduling and return of results to
participants for Rite Aid testing sites.
BioReference Laboratories provides COVID-19 laboratory
testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 17
states. Through Elixir, we provide pharmacy benefits and services
to approximately 4 million members nationwide. For more
information, www.riteaid.com.
###
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210204005160/en/
Chris Savarese 717-975-5718 christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Sep 2023 to Sep 2024